Rank | Gene Set | Z-score |
---|---|---|
1 | exocrine pancreas development (GO:0031017) | 8.83574477 |
2 | valine metabolic process (GO:0006573) | 8.67195342 |
3 | protein retention in ER lumen (GO:0006621) | 7.75866531 |
4 | intestinal cholesterol absorption (GO:0030299) | 7.47074459 |
5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.43276435 |
6 | digestion (GO:0007586) | 6.93919044 |
7 | branched-chain amino acid metabolic process (GO:0009081) | 6.71527535 |
8 | branched-chain amino acid catabolic process (GO:0009083) | 6.61074409 |
9 | biotin metabolic process (GO:0006768) | 6.20109961 |
10 | metanephric nephron epithelium development (GO:0072243) | 6.12693998 |
11 | transcytosis (GO:0045056) | 5.86928272 |
12 | metanephric epithelium development (GO:0072207) | 5.75913377 |
13 | ovulation from ovarian follicle (GO:0001542) | 5.71532066 |
14 | cysteine metabolic process (GO:0006534) | 5.22107587 |
15 | cobalamin metabolic process (GO:0009235) | 4.76262432 |
16 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 4.74363366 |
17 | tricarboxylic acid metabolic process (GO:0072350) | 4.55993394 |
18 | NADH metabolic process (GO:0006734) | 4.44032872 |
19 | fatty acid beta-oxidation (GO:0006635) | 4.39770428 |
20 | positive regulation of glomerulus development (GO:0090193) | 4.35830169 |
21 | lysine metabolic process (GO:0006553) | 4.29408941 |
22 | lysine catabolic process (GO:0006554) | 4.29408941 |
23 | pentose-phosphate shunt (GO:0006098) | 4.23332734 |
24 | negative regulation of metanephros development (GO:0072217) | 4.22915763 |
25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.18392426 |
26 | oxaloacetate metabolic process (GO:0006107) | 4.15950898 |
27 | response to water (GO:0009415) | 4.12887389 |
28 | COPI coating of Golgi vesicle (GO:0048205) | 4.12769584 |
29 | Golgi transport vesicle coating (GO:0048200) | 4.12769584 |
30 | nephron tubule development (GO:0072080) | 4.07841176 |
31 | fatty acid catabolic process (GO:0009062) | 4.05543232 |
32 | 2-oxoglutarate metabolic process (GO:0006103) | 4.03946747 |
33 | negative regulation of digestive system process (GO:0060457) | 3.99965119 |
34 | response to dietary excess (GO:0002021) | 3.93443924 |
35 | white fat cell differentiation (GO:0050872) | 3.89094476 |
36 | peptidyl-proline hydroxylation (GO:0019511) | 3.88885407 |
37 | NADPH regeneration (GO:0006740) | 3.87447495 |
38 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.86867509 |
39 | toxin transport (GO:1901998) | 3.86052008 |
40 | succinate metabolic process (GO:0006105) | 3.84974176 |
41 | polyol transport (GO:0015791) | 3.84838716 |
42 | fatty acid oxidation (GO:0019395) | 3.82886842 |
43 | brown fat cell differentiation (GO:0050873) | 3.81989631 |
44 | collecting duct development (GO:0072044) | 3.81250226 |
45 | actin filament depolymerization (GO:0030042) | 3.78016143 |
46 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.77087734 |
47 | lipid oxidation (GO:0034440) | 3.73726729 |
48 | mitochondrial calcium ion transport (GO:0006851) | 3.72341086 |
49 | carnitine shuttle (GO:0006853) | 3.71576984 |
50 | sterol catabolic process (GO:0016127) | 3.68724350 |
51 | cholesterol catabolic process (GO:0006707) | 3.68724350 |
52 | renal tubule development (GO:0061326) | 3.67500024 |
53 | quaternary ammonium group transport (GO:0015697) | 3.67198649 |
54 | cellular modified amino acid catabolic process (GO:0042219) | 3.66421206 |
55 | leukotriene biosynthetic process (GO:0019370) | 3.61533579 |
56 | aspartate family amino acid catabolic process (GO:0009068) | 3.58972727 |
57 | nephron epithelium development (GO:0072009) | 3.58741455 |
58 | short-chain fatty acid metabolic process (GO:0046459) | 3.57137988 |
59 | response to parathyroid hormone (GO:0071107) | 3.54221477 |
60 | amino-acid betaine transport (GO:0015838) | 3.53761314 |
61 | carnitine transport (GO:0015879) | 3.53761314 |
62 | low-density lipoprotein particle clearance (GO:0034383) | 3.53169082 |
63 | fatty acid transmembrane transport (GO:1902001) | 3.51971329 |
64 | triglyceride catabolic process (GO:0019433) | 3.48889531 |
65 | positive regulation of metanephros development (GO:0072216) | 3.46745731 |
66 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.43693897 |
67 | sulfur amino acid catabolic process (GO:0000098) | 3.40435000 |
68 | endocrine hormone secretion (GO:0060986) | 3.40225423 |
69 | cell volume homeostasis (GO:0006884) | 3.36358782 |
70 | response to mercury ion (GO:0046689) | 3.33593258 |
71 | regulation of sequestering of triglyceride (GO:0010889) | 3.33547836 |
72 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.31976855 |
73 | establishment of skin barrier (GO:0061436) | 3.31231681 |
74 | carnitine transmembrane transport (GO:1902603) | 3.31043484 |
75 | positive regulation of nuclease activity (GO:0032075) | 3.30819859 |
76 | tricarboxylic acid cycle (GO:0006099) | 3.28895895 |
77 | glycolipid catabolic process (GO:0019377) | 3.28142565 |
78 | fucose catabolic process (GO:0019317) | 3.26858596 |
79 | L-fucose metabolic process (GO:0042354) | 3.26858596 |
80 | L-fucose catabolic process (GO:0042355) | 3.26858596 |
81 | monocarboxylic acid catabolic process (GO:0072329) | 3.25437235 |
82 | galactose catabolic process (GO:0019388) | 3.19635104 |
83 | prostate gland growth (GO:0060736) | 3.14920784 |
84 | creatine metabolic process (GO:0006600) | 3.14194575 |
85 | proline biosynthetic process (GO:0006561) | 3.13973661 |
86 | regulation of water loss via skin (GO:0033561) | 3.12836040 |
87 | neutral lipid catabolic process (GO:0046461) | 3.12831357 |
88 | acylglycerol catabolic process (GO:0046464) | 3.12831357 |
89 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.07991332 |
90 | negative regulation of gluconeogenesis (GO:0045721) | 3.07515193 |
91 | acetyl-CoA metabolic process (GO:0006084) | 3.07177609 |
92 | protein hydroxylation (GO:0018126) | 3.06941123 |
93 | ovulation (GO:0030728) | 3.03619988 |
94 | membrane lipid catabolic process (GO:0046466) | 3.03500623 |
95 | L-serine transport (GO:0015825) | 3.01511743 |
96 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.01087376 |
97 | intestinal absorption (GO:0050892) | 3.00707465 |
98 | iron ion import (GO:0097286) | 3.00560490 |
99 | homocysteine metabolic process (GO:0050667) | 3.00124732 |
100 | lipid particle organization (GO:0034389) | 2.99984720 |
101 | hexose catabolic process (GO:0019320) | 2.99484054 |
102 | renal absorption (GO:0070293) | 2.99109103 |
103 | protein heterotrimerization (GO:0070208) | 2.97516137 |
104 | glycerolipid catabolic process (GO:0046503) | 2.97433562 |
105 | lipid storage (GO:0019915) | 2.97195245 |
106 | phosphate ion homeostasis (GO:0055062) | 2.96735577 |
107 | trivalent inorganic anion homeostasis (GO:0072506) | 2.96735577 |
108 | coenzyme A biosynthetic process (GO:0015937) | 2.96045298 |
109 | regulation of nuclease activity (GO:0032069) | 2.95457062 |
110 | cellular response to unfolded protein (GO:0034620) | 2.95166717 |
111 | response to endoplasmic reticulum stress (GO:0034976) | 2.92305622 |
112 | cranial nerve morphogenesis (GO:0021602) | 2.91745988 |
113 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.90876875 |
114 | organic cation transport (GO:0015695) | 2.89949422 |
115 | water transport (GO:0006833) | 2.87138405 |
116 | regulation of fatty acid oxidation (GO:0046320) | 2.86441769 |
117 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.85646153 |
118 | peptide catabolic process (GO:0043171) | 2.84423422 |
119 | mammary gland alveolus development (GO:0060749) | 2.83710887 |
120 | triglyceride metabolic process (GO:0006641) | 2.83120288 |
121 | cGMP-mediated signaling (GO:0019934) | 2.83061438 |
122 | growth hormone receptor signaling pathway (GO:0060396) | 2.82868105 |
123 | thioester biosynthetic process (GO:0035384) | 2.81212738 |
124 | acyl-CoA biosynthetic process (GO:0071616) | 2.81212738 |
125 | fatty acid homeostasis (GO:0055089) | 2.80817165 |
126 | coenzyme A metabolic process (GO:0015936) | 2.80323801 |
127 | negative regulation of macrophage differentiation (GO:0045650) | 2.80115362 |
128 | ER-nucleus signaling pathway (GO:0006984) | 2.79980957 |
129 | positive regulation of fatty acid oxidation (GO:0046321) | 2.79907125 |
130 | monosaccharide catabolic process (GO:0046365) | 2.79836347 |
131 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.79822771 |
132 | cellular response to topologically incorrect protein (GO:0035967) | 2.78906956 |
133 | excretion (GO:0007588) | 2.78825017 |
134 | metanephric tubule development (GO:0072170) | 2.78616869 |
135 | metanephric nephron tubule development (GO:0072234) | 2.78616869 |
136 | definitive hemopoiesis (GO:0060216) | 2.78567197 |
137 | response to growth hormone (GO:0060416) | 2.78187920 |
138 | GDP-mannose metabolic process (GO:0019673) | 2.77305391 |
139 | keratinization (GO:0031424) | 2.77272733 |
140 | response to phenylpropanoid (GO:0080184) | 2.76838457 |
141 | proline metabolic process (GO:0006560) | 2.76615753 |
142 | fucose metabolic process (GO:0006004) | 2.76380746 |
143 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.75726247 |
144 | negative regulation of amino acid transport (GO:0051956) | 2.75182754 |
145 | clathrin coat assembly (GO:0048268) | 2.73418125 |
146 | regulation of cholesterol efflux (GO:0010874) | 2.68430298 |
147 | negative regulation of appetite (GO:0032099) | 2.67909960 |
148 | negative regulation of response to food (GO:0032096) | 2.67909960 |
149 | regulation of glomerulus development (GO:0090192) | 2.67345294 |
150 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.66162830 |
151 | response to copper ion (GO:0046688) | 2.64961965 |
152 | multicellular organismal water homeostasis (GO:0050891) | 2.64477516 |
153 | negative regulation of kidney development (GO:0090185) | 2.62092751 |
154 | response to lead ion (GO:0010288) | 2.59507904 |
155 | activation of protein kinase A activity (GO:0034199) | 2.56932353 |
156 | cardiovascular system development (GO:0072358) | 2.55300076 |
157 | fluid transport (GO:0042044) | 2.54815465 |
158 | response to thyroid hormone (GO:0097066) | 2.54812255 |
159 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.54516219 |
160 | regulation of gonadotropin secretion (GO:0032276) | 2.53071333 |
161 | cellular response to growth hormone stimulus (GO:0071378) | 2.52389681 |
162 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.51201899 |
163 | dendritic spine morphogenesis (GO:0060997) | 2.50431436 |
164 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.50320665 |
165 | water homeostasis (GO:0030104) | 2.50017840 |
166 | amino-acid betaine metabolic process (GO:0006577) | 2.49149628 |
167 | retinol metabolic process (GO:0042572) | 2.49135044 |
168 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.48765552 |
169 | metanephric mesenchyme development (GO:0072075) | 2.47636171 |
170 | diacylglycerol metabolic process (GO:0046339) | 2.47236029 |
171 | camera-type eye morphogenesis (GO:0048593) | 2.47143152 |
172 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.45862726 |
173 | regulation of protein localization to cell surface (GO:2000008) | 2.45466997 |
174 | phosphate ion transport (GO:0006817) | 2.44943706 |
175 | glomerular filtration (GO:0003094) | 2.44337693 |
176 | inositol metabolic process (GO:0006020) | 2.43915226 |
177 | urate metabolic process (GO:0046415) | 2.42976396 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.14664562 |
2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.87420554 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.46364846 |
4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.36662920 |
5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.32760902 |
6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.20156396 |
7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.75779671 |
8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.64129733 |
9 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.48956574 |
10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.40085728 |
11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.37100714 |
12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.33541653 |
13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.23007176 |
14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.18911983 |
15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.18673813 |
16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.18128765 |
17 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17750102 |
18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.17723873 |
19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.08396454 |
20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.03985289 |
21 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.00629496 |
22 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.99309403 |
23 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98507332 |
24 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.96720910 |
25 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.96720910 |
26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.94887416 |
27 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.94367276 |
28 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.92904537 |
29 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.91869258 |
30 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.90184477 |
31 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.83852656 |
32 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.80121196 |
33 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.79494919 |
34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.75972806 |
35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74378823 |
36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72345540 |
37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.70692896 |
38 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.70475899 |
39 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.69270156 |
40 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.69226201 |
41 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.67706635 |
42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.67314593 |
43 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66838893 |
44 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.66119758 |
45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59358119 |
46 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.59106922 |
47 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.57853387 |
48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.55698672 |
49 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55430237 |
50 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.53787822 |
51 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.51398751 |
52 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.50733457 |
53 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.50564319 |
54 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.49487152 |
55 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.47684931 |
56 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.47676673 |
57 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45950872 |
58 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.45032335 |
59 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44684385 |
60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43826593 |
61 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.42264598 |
62 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40507276 |
63 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35745082 |
64 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35565440 |
65 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.34326668 |
66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.33930027 |
67 | MYC_22102868_ChIP-Seq_BL_Human | 1.32003219 |
68 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31961523 |
69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29812647 |
70 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29368571 |
71 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27153008 |
72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26818389 |
73 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26588969 |
74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25062546 |
75 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.24391295 |
76 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.24186524 |
77 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.24157461 |
78 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.24016985 |
79 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21841395 |
80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20146505 |
81 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.18967771 |
82 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18065741 |
83 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17926417 |
84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17134256 |
85 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16984314 |
86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16714322 |
87 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15878205 |
88 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15828917 |
89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15800140 |
90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15707646 |
91 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14779162 |
92 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14429881 |
93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.13960154 |
94 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13443989 |
95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13400869 |
96 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.13106690 |
97 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.12687458 |
98 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12200909 |
99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11562369 |
100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11538053 |
101 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.10778464 |
102 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10760183 |
103 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.10554147 |
104 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.10542718 |
105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09020419 |
106 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09000843 |
107 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08970347 |
108 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08609406 |
109 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07692341 |
110 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.07043702 |
111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06957112 |
112 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06321058 |
113 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06161796 |
114 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.05988785 |
115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05654650 |
116 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05614414 |
117 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04646591 |
118 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04575844 |
119 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04452354 |
120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03880478 |
121 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03567264 |
122 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03382946 |
123 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02328327 |
124 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01984257 |
125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00108241 |
126 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00064717 |
127 | CBP_21632823_ChIP-Seq_H3396_Human | 0.99523084 |
128 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98487125 |
129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98147040 |
130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98147040 |
131 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97805169 |
132 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97510516 |
133 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97101412 |
134 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96685369 |
135 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96104244 |
136 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95024642 |
137 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94891541 |
138 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94772623 |
139 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94170288 |
140 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 0.94111139 |
141 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93901594 |
142 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93712369 |
143 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92926199 |
144 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92673812 |
145 | P68_20966046_ChIP-Seq_HELA_Human | 0.92177429 |
146 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91675576 |
147 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91575879 |
148 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.91566061 |
149 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.91490666 |
150 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.91324661 |
151 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91259616 |
152 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91083473 |
153 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.89132756 |
154 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88686917 |
155 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.88199038 |
156 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.88199038 |
157 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88171643 |
158 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87916789 |
159 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.87876587 |
160 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87583906 |
161 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87184602 |
162 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86961961 |
163 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86340892 |
164 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.85131845 |
165 | P300_27268052_Chip-Seq_Bcells_Human | 0.84571639 |
166 | * TBL1_22424771_ChIP-Seq_293T_Human | 0.84166465 |
167 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.84090052 |
168 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.83944662 |
169 | * MYB_26560356_Chip-Seq_TH2_Human | 0.83917437 |
170 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83445262 |
171 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83411738 |
172 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.82816777 |
173 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82789580 |
174 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81486798 |
175 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.81378814 |
176 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80619456 |
177 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80213606 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001666_abnormal_nutrient_absorption | 5.33714678 |
2 | MP0005670_abnormal_white_adipose | 4.63108535 |
3 | MP0005220_abnormal_exocrine_pancreas | 4.60089565 |
4 | MP0005083_abnormal_biliary_tract | 4.53638734 |
5 | MP0005365_abnormal_bile_salt | 4.28781942 |
6 | MP0005666_abnormal_adipose_tissue | 3.11478881 |
7 | MP0004043_abnormal_pH_regulation | 3.07958074 |
8 | MP0003959_abnormal_lean_body | 2.79183952 |
9 | MP0005084_abnormal_gallbladder_morpholo | 2.78978395 |
10 | MP0002876_abnormal_thyroid_physiology | 2.78664117 |
11 | MP0009780_abnormal_chondrocyte_physiolo | 2.68994851 |
12 | MP0003868_abnormal_feces_composition | 2.67424059 |
13 | MP0004130_abnormal_muscle_cell | 2.66459222 |
14 | MP0001756_abnormal_urination | 2.65446311 |
15 | MP0005503_abnormal_tendon_morphology | 2.55713619 |
16 | MP0002796_impaired_skin_barrier | 2.51789671 |
17 | MP0005379_endocrine/exocrine_gland_phen | 2.40983788 |
18 | MP0005332_abnormal_amino_acid | 2.35611013 |
19 | MP0004185_abnormal_adipocyte_glucose | 2.34873343 |
20 | MP0005375_adipose_tissue_phenotype | 2.31480944 |
21 | * MP0009643_abnormal_urine_homeostasis | 2.30192942 |
22 | MP0003186_abnormal_redox_activity | 2.03119691 |
23 | MP0004147_increased_porphyrin_level | 1.97592983 |
24 | MP0002638_abnormal_pupillary_reflex | 1.95912281 |
25 | MP0002118_abnormal_lipid_homeostasis | 1.86226382 |
26 | MP0008438_abnormal_cutaneous_collagen | 1.81717481 |
27 | MP0001664_abnormal_digestion | 1.81436908 |
28 | MP0010329_abnormal_lipoprotein_level | 1.74558944 |
29 | MP0004019_abnormal_vitamin_homeostasis | 1.71677311 |
30 | MP0006276_abnormal_autonomic_nervous | 1.65002024 |
31 | MP0002971_abnormal_brown_adipose | 1.64803134 |
32 | MP0006036_abnormal_mitochondrial_physio | 1.64792693 |
33 | MP0005334_abnormal_fat_pad | 1.64615264 |
34 | * MP0005535_abnormal_body_temperature | 1.64223993 |
35 | MP0001873_stomach_inflammation | 1.64181619 |
36 | MP0002693_abnormal_pancreas_physiology | 1.62883326 |
37 | MP0002166_altered_tumor_susceptibility | 1.62546919 |
38 | MP0000003_abnormal_adipose_tissue | 1.62130909 |
39 | MP0001765_abnormal_ion_homeostasis | 1.58405757 |
40 | MP0005448_abnormal_energy_balance | 1.58287180 |
41 | MP0008961_abnormal_basal_metabolism | 1.51989562 |
42 | MP0003300_gastrointestinal_ulcer | 1.49774592 |
43 | MP0001944_abnormal_pancreas_morphology | 1.45344388 |
44 | MP0010234_abnormal_vibrissa_follicle | 1.45296947 |
45 | MP0002970_abnormal_white_adipose | 1.45265627 |
46 | MP0003191_abnormal_cellular_cholesterol | 1.43753544 |
47 | MP0002108_abnormal_muscle_morphology | 1.42044870 |
48 | MP0002136_abnormal_kidney_physiology | 1.41601194 |
49 | MP0009384_cardiac_valve_regurgitation | 1.38287238 |
50 | MP0005636_abnormal_mineral_homeostasis | 1.37776177 |
51 | MP0002078_abnormal_glucose_homeostasis | 1.35757339 |
52 | MP0003011_delayed_dark_adaptation | 1.34368438 |
53 | MP0006138_congestive_heart_failure | 1.31189953 |
54 | MP0002139_abnormal_hepatobiliary_system | 1.30592491 |
55 | MP0003879_abnormal_hair_cell | 1.27288335 |
56 | MP0005248_abnormal_Harderian_gland | 1.23189358 |
57 | MP0005085_abnormal_gallbladder_physiolo | 1.21955443 |
58 | MP0001881_abnormal_mammary_gland | 1.21733634 |
59 | MP0002396_abnormal_hematopoietic_system | 1.19682178 |
60 | MP0003195_calcinosis | 1.19544710 |
61 | MP0004264_abnormal_extraembryonic_tissu | 1.18409069 |
62 | MP0009115_abnormal_fat_cell | 1.17148971 |
63 | MP0000013_abnormal_adipose_tissue | 1.16314890 |
64 | MP0000427_abnormal_hair_cycle | 1.15353671 |
65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.15021051 |
66 | MP0005501_abnormal_skin_physiology | 1.13797590 |
67 | MP0001661_extended_life_span | 1.13411133 |
68 | MP0005452_abnormal_adipose_tissue | 1.12240138 |
69 | MP0001727_abnormal_embryo_implantation | 1.10153918 |
70 | MP0010386_abnormal_urinary_bladder | 1.09659667 |
71 | MP0002928_abnormal_bile_duct | 1.08489727 |
72 | MP0001958_emphysema | 1.08063887 |
73 | MP0005058_abnormal_lysosome_morphology | 1.07970359 |
74 | MP0005319_abnormal_enzyme/_coenzyme | 1.07624868 |
75 | MP0000490_abnormal_crypts_of | 1.07409139 |
76 | MP0004215_abnormal_myocardial_fiber | 1.06754424 |
77 | MP0001764_abnormal_homeostasis | 1.06648141 |
78 | MP0003705_abnormal_hypodermis_morpholog | 1.05952767 |
79 | MP0000534_abnormal_ureter_morphology | 1.05287109 |
80 | MP0003950_abnormal_plasma_membrane | 1.03793361 |
81 | MP0002006_tumorigenesis | 1.03708922 |
82 | MP0000613_abnormal_salivary_gland | 0.99369874 |
83 | MP0002896_abnormal_bone_mineralization | 0.98745177 |
84 | MP0000609_abnormal_liver_physiology | 0.97858467 |
85 | * MP0003638_abnormal_response/metabolism_ | 0.96802818 |
86 | MP0003690_abnormal_glial_cell | 0.96027521 |
87 | MP0002168_other_aberrant_phenotype | 0.94482004 |
88 | MP0003279_aneurysm | 0.93380546 |
89 | MP0002295_abnormal_pulmonary_circulatio | 0.92914722 |
90 | MP0001346_abnormal_lacrimal_gland | 0.92624762 |
91 | MP0001879_abnormal_lymphatic_vessel | 0.92123962 |
92 | MP0006054_spinal_hemorrhage | 0.89032091 |
93 | MP0004084_abnormal_cardiac_muscle | 0.88422608 |
94 | * MP0003953_abnormal_hormone_level | 0.87146514 |
95 | MP0005360_urolithiasis | 0.87073163 |
96 | MP0003724_increased_susceptibility_to | 0.85937697 |
97 | MP0004272_abnormal_basement_membrane | 0.85858027 |
98 | MP0000343_altered_response_to | 0.85063654 |
99 | MP0000371_diluted_coat_color | 0.84646469 |
100 | MP0000465_gastrointestinal_hemorrhage | 0.83711870 |
101 | MP0003656_abnormal_erythrocyte_physiolo | 0.83589792 |
102 | MP0003183_abnormal_peptide_metabolism | 0.83136343 |
103 | MP0004233_abnormal_muscle_weight | 0.83129703 |
104 | MP0009765_abnormal_xenobiotic_induced | 0.82702096 |
105 | MP0001663_abnormal_digestive_system | 0.82620981 |
106 | MP0002135_abnormal_kidney_morphology | 0.81230921 |
107 | MP0005464_abnormal_platelet_physiology | 0.79214364 |
108 | MP0000230_abnormal_systemic_arterial | 0.78944549 |
109 | MP0002837_dystrophic_cardiac_calcinosis | 0.77701819 |
110 | MP0001845_abnormal_inflammatory_respons | 0.76051380 |
111 | MP0001544_abnormal_cardiovascular_syste | 0.75983120 |
112 | MP0005385_cardiovascular_system_phenoty | 0.75983120 |
113 | MP0005647_abnormal_sex_gland | 0.74441013 |
114 | MP0003045_fibrosis | 0.74027648 |
115 | MP0002254_reproductive_system_inflammat | 0.73577943 |
116 | MP0002069_abnormal_eating/drinking_beha | 0.71092206 |
117 | MP0000598_abnormal_liver_morphology | 0.68196321 |
118 | MP0005275_abnormal_skin_tensile | 0.68149701 |
119 | MP0000538_abnormal_urinary_bladder | 0.67850237 |
120 | MP0003828_pulmonary_edema | 0.64771346 |
121 | MP0003948_abnormal_gas_homeostasis | 0.64641422 |
122 | MP0002009_preneoplasia | 0.64592602 |
123 | MP0001348_abnormal_lacrimal_gland | 0.64378147 |
124 | MP0001919_abnormal_reproductive_system | 0.63007708 |
125 | MP0008469_abnormal_protein_level | 0.62955549 |
126 | MP0005165_increased_susceptibility_to | 0.61996232 |
127 | MP0005310_abnormal_salivary_gland | 0.61181228 |
128 | MP0002909_abnormal_adrenal_gland | 0.61115186 |
129 | * MP0009642_abnormal_blood_homeostasis | 0.60909339 |
130 | MP0005620_abnormal_muscle_contractility | 0.60844831 |
131 | MP0010678_abnormal_skin_adnexa | 0.60494632 |
132 | MP0004858_abnormal_nervous_system | 0.59576807 |
133 | MP0003763_abnormal_thymus_physiology | 0.59248741 |
134 | MP0000685_abnormal_immune_system | 0.58662131 |
135 | MP0001270_distended_abdomen | 0.57881134 |
136 | MP0004808_abnormal_hematopoietic_stem | 0.56946310 |
137 | MP0002089_abnormal_postnatal_growth/wei | 0.56025240 |
138 | MP0000681_abnormal_thyroid_gland | 0.55421551 |
139 | MP0003795_abnormal_bone_structure | 0.54829107 |
140 | MP0004036_abnormal_muscle_relaxation | 0.54463992 |
141 | MP0009703_decreased_birth_body | 0.54339490 |
142 | MP0003942_abnormal_urinary_system | 0.53313254 |
143 | MP0000778_abnormal_nervous_system | 0.52700375 |
144 | MP0000627_abnormal_mammary_gland | 0.51585772 |
145 | MP0005595_abnormal_vascular_smooth | 0.50612865 |
146 | MP0004085_abnormal_heartbeat | 0.50076629 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Metabolic alkalosis (HP:0200114) | 6.03713305 |
2 | Hypokalemic alkalosis (HP:0001949) | 5.87764556 |
3 | Abnormality of chloride homeostasis (HP:0011422) | 5.18555522 |
4 | Hypomagnesemia (HP:0002917) | 4.90097540 |
5 | Hyperactive renin-angiotensin system (HP:0000841) | 4.89984436 |
6 | Renal salt wasting (HP:0000127) | 4.85820954 |
7 | Hyperglycinuria (HP:0003108) | 4.83574072 |
8 | Increased circulating renin level (HP:0000848) | 4.61354301 |
9 | Gout (HP:0001997) | 4.59076838 |
10 | Polyuria (HP:0000103) | 4.40651943 |
11 | Abnormality of magnesium homeostasis (HP:0004921) | 4.40489218 |
12 | Abnormality of renal excretion (HP:0011036) | 4.30306612 |
13 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.21383725 |
14 | Hyperaldosteronism (HP:0000859) | 4.19875130 |
15 | Abnormal urine output (HP:0012590) | 4.19322614 |
16 | Abnormality of glycine metabolism (HP:0010895) | 3.77680263 |
17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.77680263 |
18 | Ketoacidosis (HP:0001993) | 3.57906829 |
19 | Ketosis (HP:0001946) | 3.45365242 |
20 | Hyperuricemia (HP:0002149) | 3.29210251 |
21 | Increased purine levels (HP:0004368) | 3.29210251 |
22 | Polydipsia (HP:0001959) | 3.22507583 |
23 | Abnormal drinking behavior (HP:0030082) | 3.22507583 |
24 | Generalized aminoaciduria (HP:0002909) | 3.13794692 |
25 | Alkalosis (HP:0001948) | 3.05734875 |
26 | Abnormality of proline metabolism (HP:0010907) | 3.01472762 |
27 | Hydroxyprolinuria (HP:0003080) | 3.01472762 |
28 | Tetany (HP:0001281) | 2.99395591 |
29 | Oligomenorrhea (HP:0000876) | 2.96856796 |
30 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.94354384 |
31 | Tubular atrophy (HP:0000092) | 2.91015813 |
32 | Hypokalemia (HP:0002900) | 2.88114648 |
33 | Pancreatitis (HP:0001733) | 2.86241747 |
34 | Abnormality of renin-angiotensin system (HP:0000847) | 2.85660248 |
35 | Decreased subcutaneous fat (HP:0001002) | 2.78594734 |
36 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.74945624 |
37 | Dicarboxylic aciduria (HP:0003215) | 2.74945624 |
38 | Potter facies (HP:0002009) | 2.68321379 |
39 | Facial shape deformation (HP:0011334) | 2.68321379 |
40 | Adrenal overactivity (HP:0002717) | 2.62060806 |
41 | Abnormality of purine metabolism (HP:0004352) | 2.60004403 |
42 | Steatorrhea (HP:0002570) | 2.58711894 |
43 | Short chin (HP:0000331) | 2.58108865 |
44 | Proximal tubulopathy (HP:0000114) | 2.56582808 |
45 | Chondrocalcinosis (HP:0000934) | 2.53806973 |
46 | Hypoglycemic coma (HP:0001325) | 2.51867916 |
47 | Aortic aneurysm (HP:0004942) | 2.50765302 |
48 | Vacuolated lymphocytes (HP:0001922) | 2.48387429 |
49 | Abnormal platelet function (HP:0011869) | 2.45107305 |
50 | Impaired platelet aggregation (HP:0003540) | 2.45107305 |
51 | Type I diabetes mellitus (HP:0100651) | 2.41170809 |
52 | Abnormality of Sharpey fibers (HP:0100685) | 2.41129268 |
53 | Hyperglycinemia (HP:0002154) | 2.39240828 |
54 | Long foot (HP:0001833) | 2.37885978 |
55 | Nephrocalcinosis (HP:0000121) | 2.37603299 |
56 | Hypertriglyceridemia (HP:0002155) | 2.37426618 |
57 | Abnormality of nail color (HP:0100643) | 2.36532462 |
58 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.35137435 |
59 | Large hands (HP:0001176) | 2.34680029 |
60 | Abnormality of the intrinsic pathway (HP:0010989) | 2.31545503 |
61 | Acanthosis nigricans (HP:0000956) | 2.30612264 |
62 | Tubulointerstitial fibrosis (HP:0005576) | 2.29943715 |
63 | Large eyes (HP:0001090) | 2.29308455 |
64 | Beaking of vertebral bodies (HP:0004568) | 2.28640809 |
65 | Polyphagia (HP:0002591) | 2.28262729 |
66 | Abnormality of the lumbar spine (HP:0100712) | 2.24261207 |
67 | Increased muscle lipid content (HP:0009058) | 2.24131015 |
68 | Abnormality of sodium homeostasis (HP:0010931) | 2.22596846 |
69 | Hyperammonemia (HP:0001987) | 2.21276647 |
70 | Abnormality of potassium homeostasis (HP:0011042) | 2.21102708 |
71 | Abnormal eating behavior (HP:0100738) | 2.20053514 |
72 | Dysostosis multiplex (HP:0000943) | 2.18462183 |
73 | Hypercalciuria (HP:0002150) | 2.18252137 |
74 | Hepatic necrosis (HP:0002605) | 2.17917762 |
75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16628725 |
76 | Mucopolysacchariduria (HP:0008155) | 2.16628725 |
77 | Growth hormone excess (HP:0000845) | 2.14691760 |
78 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.12719625 |
79 | Bone cyst (HP:0012062) | 2.09996298 |
80 | Progressive muscle weakness (HP:0003323) | 2.09636780 |
81 | Methylmalonic aciduria (HP:0012120) | 2.09548468 |
82 | Concave nail (HP:0001598) | 2.09274409 |
83 | Petechiae (HP:0000967) | 2.08941399 |
84 | Hypoplasia of the pons (HP:0012110) | 2.06146688 |
85 | Rectal prolapse (HP:0002035) | 2.05756353 |
86 | Hypothermia (HP:0002045) | 2.05718684 |
87 | Thoracolumbar scoliosis (HP:0002944) | 2.04400187 |
88 | Myoglobinuria (HP:0002913) | 2.04318142 |
89 | Persistence of primary teeth (HP:0006335) | 2.04251321 |
90 | Generalized muscle weakness (HP:0003324) | 2.03213690 |
91 | Joint stiffness (HP:0001387) | 2.03022473 |
92 | Dehydration (HP:0001944) | 2.02976602 |
93 | Vomiting (HP:0002013) | 2.02260550 |
94 | Hyperphosphaturia (HP:0003109) | 2.01786606 |
95 | Hypotension (HP:0002615) | 2.00841684 |
96 | Thoracic kyphosis (HP:0002942) | 1.99502782 |
97 | Rickets (HP:0002748) | 1.97287318 |
98 | Metaphyseal dysplasia (HP:0100255) | 1.96273619 |
99 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95378857 |
100 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95378857 |
101 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95378857 |
102 | Fatigue (HP:0012378) | 1.95378036 |
103 | Exocrine pancreatic insufficiency (HP:0001738) | 1.94237231 |
104 | Hypoproteinemia (HP:0003075) | 1.91996652 |
105 | Fat malabsorption (HP:0002630) | 1.91463459 |
106 | Hyponatremia (HP:0002902) | 1.88910780 |
107 | Limb hypertonia (HP:0002509) | 1.87885535 |
108 | Lymphangioma (HP:0100764) | 1.85442580 |
109 | Abnormality of alanine metabolism (HP:0010916) | 1.85293065 |
110 | Hyperalaninemia (HP:0003348) | 1.85293065 |
111 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85293065 |
112 | Prenatal maternal abnormality (HP:0002686) | 1.85155153 |
113 | Metabolic acidosis (HP:0001942) | 1.82791290 |
114 | Osteopenia (HP:0000938) | 1.82275887 |
115 | Nausea (HP:0002018) | 1.80258567 |
116 | Prolonged bleeding time (HP:0003010) | 1.80187777 |
117 | Menorrhagia (HP:0000132) | 1.79598051 |
118 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.79577250 |
119 | Abnormal glycosylation (HP:0012345) | 1.79577250 |
120 | Nephrogenic diabetes insipidus (HP:0009806) | 1.79175774 |
121 | Neonatal onset (HP:0003623) | 1.78750290 |
122 | Cortical dysplasia (HP:0002539) | 1.77830742 |
123 | Abnormal urine phosphate concentration (HP:0012599) | 1.75060744 |
124 | Abnormality of urine glucose concentration (HP:0011016) | 1.72508121 |
125 | Glycosuria (HP:0003076) | 1.72508121 |
126 | Abnormality of molar morphology (HP:0011070) | 1.71761597 |
127 | Abnormality of molar (HP:0011077) | 1.71761597 |
128 | Skin nodule (HP:0200036) | 1.70351646 |
129 | Termporal pattern (HP:0011008) | 1.66531369 |
130 | Insidious onset (HP:0003587) | 1.66531369 |
131 | Abnormality of permanent molar morphology (HP:0011071) | 1.64918076 |
132 | Abnormality of the dental root (HP:0006486) | 1.64918076 |
133 | Taurodontia (HP:0000679) | 1.64918076 |
134 | Tubulointerstitial abnormality (HP:0001969) | 1.63968481 |
135 | Sparse lateral eyebrow (HP:0005338) | 1.63843521 |
136 | Decreased circulating renin level (HP:0003351) | 1.63471884 |
137 | Focal segmental glomerulosclerosis (HP:0000097) | 1.61319581 |
138 | Hypophosphatemia (HP:0002148) | 1.60728222 |
139 | Prominent supraorbital ridges (HP:0000336) | 1.59462664 |
140 | Pigmentary retinal degeneration (HP:0001146) | 1.57283424 |
141 | Broad metatarsal (HP:0001783) | 1.53971487 |
142 | Thin bony cortex (HP:0002753) | 1.53781447 |
143 | Visceral angiomatosis (HP:0100761) | 1.53215889 |
144 | Hypercortisolism (HP:0001578) | 1.53076449 |
145 | Abnormality of the dental pulp (HP:0006479) | 1.51430430 |
146 | Abnormality of renal resorption (HP:0011038) | 1.49526800 |
147 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.48574602 |
148 | Glomerulosclerosis (HP:0000096) | 1.45052241 |
149 | Infantile muscular hypotonia (HP:0008947) | 1.44251029 |
150 | Accelerated skeletal maturation (HP:0005616) | 1.43224345 |
151 | Right ventricular cardiomyopathy (HP:0011663) | 1.40214346 |
152 | Neoplasm of the heart (HP:0100544) | 1.37599339 |
153 | Polycythemia (HP:0001901) | 1.37365920 |
154 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.36531660 |
155 | Advanced eruption of teeth (HP:0006288) | 1.35921717 |
156 | Hemangiomatosis (HP:0007461) | 1.35904586 |
157 | Unilateral renal agenesis (HP:0000122) | 1.35721520 |
158 | Intellectual disability, moderate (HP:0002342) | 1.35213578 |
159 | Hypotrichosis (HP:0001006) | 1.34859813 |
160 | Conjunctival hamartoma (HP:0100780) | 1.34365425 |
161 | Hyperkalemia (HP:0002153) | 1.33010714 |
162 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.32834112 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.52474306 |
2 | WNK3 | 4.47986028 |
3 | TRIB3 | 4.03547175 |
4 | ERN1 | 3.70532830 |
5 | EPHA3 | 3.31925164 |
6 | CAMK1D | 2.87963440 |
7 | MAPKAPK3 | 2.72609849 |
8 | OXSR1 | 2.54426820 |
9 | PKN2 | 2.49337413 |
10 | SCYL2 | 2.44526909 |
11 | EEF2K | 2.41802303 |
12 | WNK4 | 2.41470384 |
13 | EPHB1 | 2.40434974 |
14 | LMTK2 | 2.03890133 |
15 | FLT3 | 1.87113104 |
16 | EIF2AK3 | 1.86930857 |
17 | PDK4 | 1.83870037 |
18 | PDK3 | 1.83870037 |
19 | MAP2K2 | 1.78833525 |
20 | FRK | 1.76976184 |
21 | CAMK1G | 1.76518262 |
22 | FER | 1.74999896 |
23 | SIK1 | 1.73801199 |
24 | MARK1 | 1.57199720 |
25 | TESK1 | 1.44165360 |
26 | MAP2K3 | 1.42921711 |
27 | ZAP70 | 1.40959931 |
28 | PDK2 | 1.35280259 |
29 | DMPK | 1.34326536 |
30 | CAMKK2 | 1.34143422 |
31 | LRRK2 | 1.32507913 |
32 | NME2 | 1.28576936 |
33 | KIT | 1.28468335 |
34 | BMPR2 | 1.19456840 |
35 | RPS6KB2 | 1.13499571 |
36 | MAP2K1 | 1.11697605 |
37 | TAOK3 | 1.09788259 |
38 | MAP2K7 | 1.06002457 |
39 | ERBB3 | 1.02614537 |
40 | DDR2 | 1.01369716 |
41 | IRAK3 | 0.99919807 |
42 | LATS2 | 0.98862777 |
43 | TGFBR2 | 0.96635351 |
44 | NTRK3 | 0.95709455 |
45 | RET | 0.93527933 |
46 | ICK | 0.91616487 |
47 | MAP4K1 | 0.91299162 |
48 | TIE1 | 0.89549823 |
49 | TRPM7 | 0.89488720 |
50 | MAPKAPK5 | 0.88207876 |
51 | MATK | 0.87651459 |
52 | INSRR | 0.87186876 |
53 | PAK2 | 0.86032830 |
54 | MST1R | 0.84604692 |
55 | STK3 | 0.79254649 |
56 | PIM2 | 0.79212698 |
57 | MAP3K4 | 0.77945310 |
58 | CASK | 0.77436956 |
59 | PRKAA2 | 0.71604838 |
60 | JAK3 | 0.70929388 |
61 | TBK1 | 0.69765960 |
62 | PDK1 | 0.69479769 |
63 | PIK3CA | 0.69319451 |
64 | MAP3K3 | 0.68684631 |
65 | MAP3K6 | 0.68262891 |
66 | MARK2 | 0.68046121 |
67 | PDPK1 | 0.65294851 |
68 | DYRK2 | 0.64841944 |
69 | MAP2K4 | 0.63595907 |
70 | MAP2K6 | 0.63212846 |
71 | TEC | 0.62351514 |
72 | FGFR3 | 0.59572642 |
73 | BCR | 0.59429828 |
74 | NTRK1 | 0.59066570 |
75 | DYRK3 | 0.58440177 |
76 | NME1 | 0.58262073 |
77 | PINK1 | 0.57773907 |
78 | MINK1 | 0.56618512 |
79 | JAK2 | 0.56395268 |
80 | BTK | 0.56155256 |
81 | CAMKK1 | 0.55748934 |
82 | PTK6 | 0.55517682 |
83 | WNK1 | 0.54577355 |
84 | CDK19 | 0.53446459 |
85 | BRSK2 | 0.53065211 |
86 | KSR2 | 0.52861415 |
87 | MAPK13 | 0.52595840 |
88 | PRKG2 | 0.52433999 |
89 | ADRBK1 | 0.52344526 |
90 | TGFBR1 | 0.52317476 |
91 | PRKAA1 | 0.51932379 |
92 | MTOR | 0.50511201 |
93 | CSF1R | 0.50442316 |
94 | GSK3A | 0.49578099 |
95 | EPHB2 | 0.48170282 |
96 | ILK | 0.47893892 |
97 | MAPK4 | 0.47396692 |
98 | SGK1 | 0.47396627 |
99 | HIPK2 | 0.47191658 |
100 | GRK5 | 0.45564136 |
101 | LATS1 | 0.41737010 |
102 | IRAK4 | 0.41484741 |
103 | RPS6KB1 | 0.41371147 |
104 | PDGFRB | 0.41290738 |
105 | SGK223 | 0.41063287 |
106 | SGK494 | 0.41063287 |
107 | MAP3K2 | 0.40743597 |
108 | MYLK | 0.40380868 |
109 | DAPK2 | 0.39486117 |
110 | RPS6KA2 | 0.38235851 |
111 | PRKG1 | 0.37998532 |
112 | PIK3CG | 0.37497051 |
113 | CDK9 | 0.37151422 |
114 | PRKD1 | 0.36915448 |
115 | PDGFRA | 0.36730060 |
116 | DYRK1B | 0.36638989 |
117 | CDK6 | 0.36468435 |
118 | PKN1 | 0.36004097 |
119 | ABL2 | 0.35795381 |
120 | STK39 | 0.34078570 |
121 | MAPK11 | 0.33656309 |
122 | PAK3 | 0.33511097 |
123 | KSR1 | 0.33475941 |
124 | MAP3K7 | 0.32919457 |
125 | MAPK12 | 0.32871487 |
126 | NLK | 0.32795648 |
127 | SGK2 | 0.32648072 |
128 | RIPK1 | 0.31079131 |
129 | CAMK1 | 0.31053185 |
130 | RPS6KA3 | 0.30330041 |
131 | DAPK1 | 0.29954028 |
132 | CLK1 | 0.29765312 |
133 | MAP3K1 | 0.29220367 |
134 | STK38L | 0.28537952 |
135 | FGFR2 | 0.27220377 |
136 | JAK1 | 0.27009836 |
137 | PRKACA | 0.26985916 |
138 | MAPK15 | 0.26963230 |
139 | GRK1 | 0.26054893 |
140 | TAOK1 | 0.25639909 |
141 | IGF1R | 0.25556066 |
142 | PRKCG | 0.25500648 |
143 | CDK5 | 0.25447399 |
144 | EIF2AK1 | 0.25129775 |
145 | RAF1 | 0.24866999 |
146 | IRAK2 | 0.24508116 |
147 | MAPK7 | 0.24338274 |
148 | MAPK3 | 0.23887511 |
149 | PRKACB | 0.23780841 |
150 | PRKACG | 0.23286055 |
151 | TYK2 | 0.22224994 |
152 | SGK3 | 0.21594340 |
153 | ACVR1B | 0.21148242 |
154 | PRKCH | 0.20828971 |
155 | IRAK1 | 0.19158434 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Pancreatic secretion_Homo sapiens_hsa04972 | 4.73812182 |
2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.34915243 |
3 | Protein digestion and absorption_Homo sapiens_hsa04974 | 3.95331512 |
4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.77858831 |
5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.58262671 |
6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.53710251 |
7 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.38999686 |
8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.84343115 |
9 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.53148820 |
10 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.30252541 |
11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.28062083 |
12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.20376487 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.15417749 |
14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.14314373 |
15 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.08817727 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06670432 |
17 | Protein export_Homo sapiens_hsa03060 | 1.89686355 |
18 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.82244722 |
19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.69769344 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69748629 |
21 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.65350211 |
22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.64683989 |
23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.64049174 |
24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.51395095 |
25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.50141345 |
26 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.49085212 |
27 | Renin secretion_Homo sapiens_hsa04924 | 1.45597040 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41962071 |
29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.38962302 |
30 | Gap junction_Homo sapiens_hsa04540 | 1.34356957 |
31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.33508801 |
32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28178215 |
33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.21607424 |
34 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.21134140 |
35 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.20817769 |
36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.18494161 |
37 | Peroxisome_Homo sapiens_hsa04146 | 1.09121133 |
38 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08914145 |
39 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.08896516 |
40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.06545878 |
41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.05746326 |
42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.03962842 |
43 | Circadian entrainment_Homo sapiens_hsa04713 | 1.03640744 |
44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.03581534 |
45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00399451 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00128454 |
47 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.00012490 |
48 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97170758 |
49 | Long-term depression_Homo sapiens_hsa04730 | 0.96116725 |
50 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94704294 |
51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94511794 |
52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.93651852 |
53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91595797 |
54 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88743400 |
55 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.88739453 |
56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87229524 |
57 | Morphine addiction_Homo sapiens_hsa05032 | 0.84692553 |
58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83265948 |
59 | Focal adhesion_Homo sapiens_hsa04510 | 0.82754236 |
60 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82657782 |
61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82426318 |
62 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.77616932 |
63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77369049 |
64 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77272160 |
65 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76974538 |
66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76774738 |
67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.76123571 |
68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76096192 |
69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73987825 |
70 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73154234 |
71 | Axon guidance_Homo sapiens_hsa04360 | 0.71183409 |
72 | Melanoma_Homo sapiens_hsa05218 | 0.70438779 |
73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70047736 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.69052863 |
75 | Insulin secretion_Homo sapiens_hsa04911 | 0.68722414 |
76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68244093 |
77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.68141794 |
78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68069033 |
79 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67719068 |
80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67644700 |
81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66306080 |
82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.65577100 |
83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64859859 |
84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64121524 |
85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.63702444 |
86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63259929 |
87 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62980346 |
88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.62670192 |
89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62240712 |
90 | ABC transporters_Homo sapiens_hsa02010 | 0.61711761 |
91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61489599 |
92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60249937 |
93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59598679 |
94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59415197 |
95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59257367 |
96 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57848388 |
97 | Cocaine addiction_Homo sapiens_hsa05030 | 0.57040062 |
98 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56814696 |
99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56160648 |
100 | Salivary secretion_Homo sapiens_hsa04970 | 0.55733797 |
101 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.54980749 |
102 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54891426 |
103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54890208 |
104 | Lysosome_Homo sapiens_hsa04142 | 0.53307648 |
105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53231787 |
106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52956820 |
107 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52439841 |
108 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52406801 |
109 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51813956 |
110 | Ribosome_Homo sapiens_hsa03010 | 0.51385704 |
111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51331857 |
112 | Platelet activation_Homo sapiens_hsa04611 | 0.50586363 |
113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50209324 |
114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48592681 |
115 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47487265 |
116 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.47454874 |
117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47074576 |
118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45952095 |
119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45821503 |
120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45673621 |
121 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45070380 |
122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44919805 |
123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.44900369 |
124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44252948 |
125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40352814 |
126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40246061 |
127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39804433 |
128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37967317 |
129 | Influenza A_Homo sapiens_hsa05164 | 0.36061378 |
130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35042550 |
131 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33370579 |
132 | Parkinsons disease_Homo sapiens_hsa05012 | 0.32624623 |
133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31536189 |
134 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31494349 |
135 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31010468 |
136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28007709 |
137 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26559748 |
138 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26284871 |
139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.26022555 |
140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25155659 |
141 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.24464965 |
142 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24030177 |
143 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21699192 |
144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19381752 |
145 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.18842308 |
146 | Bile secretion_Homo sapiens_hsa04976 | 0.17972402 |
147 | Hepatitis C_Homo sapiens_hsa05160 | 0.17889476 |
148 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.17299056 |
149 | Thyroid cancer_Homo sapiens_hsa05216 | 0.16670108 |
150 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.15750540 |
151 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15633075 |
152 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.15210662 |
153 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.14746501 |
154 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.12990742 |
155 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.12609062 |
156 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.12079083 |